SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending as a significant analyst downgrade has intensified market debate around its valuation and future prospects. Many in the community are interpreting the price action as institutional maneuvering to acquire shares, citing the company's critical role in AI server infrastructure and rapid revenue expansion. Despite ongoing discussions about profitability and governance, investors are weighing SMCI's essential position in the AI sector.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending with strong community buzz fueled by a recent positive analyst rating and high short interest, igniting speculation of a potential squeeze. Investors are keenly anticipating announcements from the ongoing J.P. Morgan Healthcare Conference regarding new partnerships, strategic updates, and the broader application of its Matrix-M platform, amidst ongoing discussions about management performance.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is sparking significant discussion as investors navigate notable price volatility, often attributed to ongoing CEO stock sales and perceived market manipulation. Despite these headwinds, many remain highly bullish on PATH's robust financial position, recent GAAP profitability, and its strategic leadership in the burgeoning Agentic AI space, amplified by its S&P MidCap 400 inclusion and new leveraged ETF.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is actively trending as it pivots from Reality Labs layoffs towards a massive AI infrastructure buildout, highlighted by new "Meta Compute" initiatives and significant nuclear energy deals to power future data centers. This strategic shift is fueling intense debate, with some investors bearish on current spending and predicting further declines, while others view the moves as a fundamental re-rating opportunity and an attractive dip to buy for long-term AI-driven growth.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is heavily discussed following its pledge to bear the electricity costs for new AI data centers, a move seen by some as bullish for accelerating infrastructure growth. Despite this, community sentiment is sharply divided, with many lamenting the stock's recent underperformance compared to other major tech companies while others view current levels as a prime accumulation opportunity for its long-term AI and cloud dominance.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is a key discussion point following its new Chief Commercial Officer appointment and the completion of VK2735 maintenance study enrollment, with the J.P. Morgan Healthcare Conference amplifying investor interest. The community is deeply polarized, debating the company's best-in-class obesity drug potential and strategic moves towards commercialization or partnerships, against ongoing criticisms of leadership and perceived underperformance amidst sector peers. Many observers attribute recent price fluctuations to market manipulation within this competitive landscape.

RYVYL Inc. is a financial technology company that develops software platforms and tools that are focused on providing global payment acceptance and disbursement capabilities. It offers an innovative payment platform-as-a-service that redefines global payment solutions, enabling seamless business-to-business, consumer-to-business, and peer-to-peer transactions worldwide. The company leverages advanced electronic payment technology to deliver seamless financial solutions across global markets. It operates through two geographical segments: North America and International. The company was founded on April 10, 2007 and is headquartered in San Diego, CA.

Ryvyl Inc

Ryvyl (RVYL) is experiencing intense community interest, primarily fueled by its impending merger with Roundtable to form a Web3 digital media platform with a Bitcoin treasury. The stock's notably low float and high short interest are driving widespread speculation of a significant short squeeze, with investors also closely watching progress on Nasdaq compliance and the resolution of prior litigation.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending following its earnings report, which, despite surpassing expectations, led to a stock decline as investors focused on elevated expectations, a substantial reserve build for the Apple Card transfer, and broader credit market concerns. The community is actively debating the potential impact of a proposed cap on credit card interest rates, adding another layer of uncertainty for the banking sector. Jamie Dimon's cautious economic outlook further contributes to the conversation around financial stability.

Ambitions Enterprise Management Co. LLC operates as a travel agency. It provides event planning and management services. The firm also offers transportation, accommodations, meals, and guided tours or activities under convenient packages. The company was founded on October 26, 2023 and is headquartered in Dubai, United Arab Emirates.

Ambitions Enterprise Management Co LLC - Ordinary Shares - Class A

Ambitions Enterprise Management Co LLC

AHMA is experiencing significant momentum, driven by its extremely low public float as a recent IPO, sparking intense discussion about a potential short squeeze. The community is actively debating its trajectory, with many speculating on substantial price targets by drawing parallels to past low-float runners, while others urge caution regarding its high volatility. Amidst the speculative fervor, some traders are also highlighting the company's underlying business, focusing on its scalable energy solutions for the healthcare sector.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is trending amid political proposals for a 10% cap on credit card interest rates, sparking widespread debate about its potential impact. While some investors fear a significant stock decline, many in the community view this as an overreaction and a buying opportunity, emphasizing that Visa primarily profits from transaction fees and not direct interest charges. The broader discussion highlights Visa's robust global network and ongoing initiatives in digital payments and stablecoins as key long-term growth drivers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Summit Therapeutics (NASDAQ:SMMT) Stock Price Down 13.4% - What's Next?

Summit Therapeutics (NASDAQ:SMMT) Stock Price Down 13.4% - What's Next...

Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSKs B7-H3 Antibody Drug Conjugate (ADC)

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced it has entered into a clinical trial collaboration with GSK plc (GSK, LSE/NYSE: GSK) to evaluate ivonescimab, a novel, investigational PD-1...

Summit Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA Seeking Approval for Ivonescimab in Combination with Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC

Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking...

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Summit Therapeutics Inc. (NASDAQ: SMMT) ('Summit,' 'we,' or the 'Company') today announced the grant of inducement awards of options to purchase a collective total of up to 214,331 shares of common...

Summit Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) today announced that it will participate in and present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco...

Top Research Reports for Apple, Cisco & IBM

Apple leads today's top research reports, with Services surpassing 1B paid subscribers and expectations for double-digit iPhone growth in fiscal Q1.

Farther Finance Advisors LLC Makes New $1.14 Million Investment in Summit Therapeutics PLC $SMMT

Farther Finance Advisors LLC purchased a new position in shares of Summit Therapeutics PLC (NASDAQ:SMMT - Free Report) in the third quarter, according to its most recent filing with the Securities...

Capricorn Fund Managers Ltd Takes $10.25 Million Position in Summit Therapeutics PLC $SMMT

Capricorn Fund Managers Ltd purchased a new position in shares of Summit Therapeutics PLC (NASDAQ:SMMT - Free Report) during the third quarter, according to the company in its most recent filing with...

Summit Therapeutics PLC (NASDAQ:SMMT) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Summit Therapeutics PLC (NASDAQ:SMMT - Get Free Report) have earned an average recommendation of "Moderate Buy" from the eighteen brokerages that are currently covering the company...

Pfizer Issues Soft 2026 View: What Does It Mean for the Stock's Future?

PFE's soft 2026 outlook spooks investors, with revenue and EPS guidance trailing expectations as COVID-19 demand fades and patent losses mount.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

SMMT
Summit Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SMMT News

SMMTSummit Therapeutics Inc